Yves Claude Nicolau,Jean-Marie Lehn,Claudine Kieda
申请号：
US15145257
公开号：
US20160235771A1
申请日:
2016.05.03
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Inositol trisphosphate (ITPP) causes normalization of tumor vasculature and is a particularly effective cancer therapy when a second chemotherapeutic agent is administered following partial vascularization. ITPP also treats, alone or in combination, multi-drug resistant cancers. ITPP can also be used to reduce the amount of a second chemotherapeutic drug required for anticancer activity. In addition, ITPP enhances immune response and treats hyperproliferative disorders.
